GB-7624
GB-7624-101
Phase 1 small_molecule active
Quick answer
GB-7624 for Atopic Dermatitis (AD) is a Phase 1 program (small_molecule) at Generate Biomedicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Generate Biomedicines
- Indication
- Atopic Dermatitis (AD)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active